Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Revive Therapeutics Ltd C.RVV

Alternate Symbol(s):  RVVTF

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is... see more

CSE:RVV - Post Discussion

Revive Therapeutics Ltd > I called a Trial site today. Status quo= No Buc
View:
Post by RReis09 on Dec 22, 2020 1:38pm

I called a Trial site today. Status quo= No Buc

Just like previous calls....
Comment by whateveryousay on Dec 22, 2020 1:55pm
If you called my business I would not give you information on my operations.
Comment by RReis09 on Dec 22, 2020 3:34pm
Hey Simp! They are doing Trials Remember? Of course they would want recruits.....except they never started trials.... Boo! Afraid to call or you just buy a stocks b.s...cbd then Shrooms then covid back to Shroom news and empty shell deals......get a clue Simp!
Comment by RiskyBiz928 on Dec 22, 2020 3:42pm
Who is Simp?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities